COLD-fX® Chosen Canada's # 1 Phamracist Recommended Natural Cold Remedy For the Third Year in a Row

Edmonton, AB (CVQ – TSX) Sixty-nine percent of Canadian pharmacists polled recommend COLD-fX as their first choice among natural cold remedies to their customers – up from 55% in 2005 – according to the 14th annual Pharmacy Post and L’actualité pharmaceutique Survey of Pharmacists on OTC Counselling and Recommendations.

The survey also reveals that COLD-fX topped the recommendation’s list of Quebec pharmacists in the natural cold remedy category for the second year in a row. CV Technologies Inc., maker of COLD-fX, said today that 31% of Quebec pharmacists surveyed recommend COLD-fX ahead of all other natural cold medicines – 50% more often than its nearest competitor.

The survey was completed by 976 pharmacists between October 17 – December 10, 2007. The margin of error is ±2.6%, 18 times out of 20.

The findings will be published in the April issue of Pharmacy Post and the May issue of L’actualité pharmaceutique. The on-line survey was conducted by the research division of Rogers Business and Professional Publishing for Pharmacy Post and L’actualité pharmaceutique – the key industry publications in Canada.

The results of the survey form the basis of a comprehensive report on the over-the-counter (OTC) or non-prescription market. It measures pharmacists’ opinions and behaviours on counselling patients for nonprescription medications, and reveals which OTC brands pharmacists most often recommend to patients. “This report confirms pharmacists’ importance in helping consumers choose the right nonprescription product,” says Janet Smith, Executive Publisher of the Retail Services Group, Rogers Business and Professional Publishing. “The “Pharmacy Post/L’actualité pharmaceutique’s 14th annual OTC Market Report also provides a snapshot of the performance of 70 key nonprescription categories.” “It’s the industry’s most comprehensive report on the nonprescription market.”

Across Canada, COLD-fX has been the # 1 pharmacist-recommended natural cold remedy for three years in a row. It has also been ranked as the number one selling cold and flu remedy in Canada since October 2004. (ACNielsen’s MarketTrack Drug Service for Cold Remedies, Natural Supplements & Vitamins categories).

About Pharmacy Post magazine

Pharmacy Post is published by Rogers Publishing Ltd and is Canada’s primary source for drugstore news including OTC, business and front shop developments for pharmacists, pharmacy owners, managers and buyers.

About L’actualite pharmaceutique magazine

L’actualité pharmaceutique is published by Rogers Publishing Ltd and is a dynamic mix of news and drugstore channel information for the Quebec market.


CV Technologies, founded in 1992, is a global leader in the development and commercialization of naturally derived, evidence based, natural therapeutics for disease prevention and health maintenance. The Company's lead product - COLD-fX® - strengthens the immune system and is widely used as a leading over the counter remedy (OTC) for preventing and relieving cold and flu infections. In the United States it is marketed as an immune enhancing dietary supplement. COLD-fX continues to rank as the number one selling cold and flu remedy in Canada (ACNielsen’s MarketTrack National all Channel service for the categories of Cold Remedies and Supplements & Products, 52 weeks ending December 22, 2007). COLD-fX®, with its unique and patented mechanism of action was standardized according to the Company's ChemBioPrint (CBP) Process. The CBP process precisely identifies the chemical profile and biological activity of multi-active compounds in evidence-based natural therapeutics. The CBP process also provides a manufacturing protocol that ensures each batch of the final product delivers verifiable and provable health benefits.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.